|
C3ORF38 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.237110E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.639500E-04 |
| Normal-vs-Stage2 |
3.745400E-01 |
| Normal-vs-Stage3 |
3.385400E-01 |
| Normal-vs-Stage4 |
1.135510E-02 |
| Stage1-vs-Stage2 |
2.092000E-01 |
| Stage1-vs-Stage3 |
2.120000E-01 |
| Stage1-vs-Stage4 |
8.022000E-01 |
| Stage2-vs-Stage3 |
9.311400E-01 |
| Stage2-vs-Stage4 |
2.846200E-01 |
| Stage3-vs-Stage4 |
3.938600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.061590E-03 |
| Normal-vs-AfricanAmerican |
1.844460E-02 |
| Normal-vs-Asian |
1.866210E-01 |
| Caucasian-vs-AfricanAmerican |
8.657600E-01 |
| Caucasian-vs-Asian |
8.765200E-01 |
| AfricanAmerican-vs-Asian |
9.239000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.27140000000193E-05 |
| Normal-vs-Female |
6.635200E-01 |
| Male-vs-Female |
1.360450E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.711630E-02 |
| Normal-vs-Extreme_Weight |
1.75125999999359E-05 |
| Normal-vs-Obese |
2.452200E-02 |
| Normal-vs-Extreme_Obese |
1.144190E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.557000E-01 |
| Normal_Weight-vs-Obese |
6.876200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.352600E-01 |
| Extreme_Weight-vs-Obese |
7.718200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.241800E-01 |
| Obese-vs-Extreme_Obese |
4.609600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.089000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.881600E-03 |
| Normal-vs-Age(61-80Yrs) |
1.337940E-03 |
| Normal-vs-Age(81-100Yrs) |
6.042900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.042000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.761970E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.058000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.950000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.304000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.388600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.191790E-04 |
| Normal-VS-Type2 PRCC |
1.288290E-02 |
| Normal-VS-KIRP CIMP |
1.688100E-02 |
| Normal-VS-Unclassified PRCC |
1.076970E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.658200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.418300E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
3.253200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.060020E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.779600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.647610E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.20239999998628E-06 |
| Normal-vs-N1 |
5.937400E-01 |
| Normal-vs-N2 |
1.819970E-03 |
| N0-vs-N1 |
7.418300E-03 |
| N0-vs-N2 |
3.984200E-01 |
| N1-vs-N2 |
1.119170E-01 |
|
|
